.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT (CBC) @

Hemoglobin 13.00 g/dL 11.50 - 15.00

(Photometry)

Packed Cell Volume (PCV) 39.50 % 36.00 - 46.00

(Calculated)

RBC Count 4.22 mill/mm3 3.80 - 4.80

(Electrical Impedence)

MCV 93.50 fL 80.00 - 100.00

(Electrical Impedence)

MCH 30.80 pg 27.00 - 32.00

(Calculated)

MCHC 32.90 g/dL 32.00 - 35.00

(Calculated)

Red Cell Distribution Width (RDW) 13.80 % 11.50 - 14.50

(Electrical Impedence)

Total Leukocyte Count (TLC) 7.20 thou/mm3 4.00 - 10.00

(Electrical Impedence)

Differential Leucocyte Count (DLC)

(VCS Technology)
Segmented Neutrophils 58.90 % 40.00 - 80.00
Lymphocytes 32.00 % 20.00 - 40.00
Monocytes 6.90 % 2.00 - 10.00
Eosinophils 0.70 % 1.00 - 6.00
Basophils 1.50 % <2.00
Absolute Leucocyte Count
(Calculated)
Neutrophils 4.24 thou/mm3 2.00 - 7.00
Lymphocytes 2.30 thou/mm3 1.00 - 3.00
Monocytes 0.50 thou/mm3 0.20 - 1.00
Eosinophils 0.05 thou/mm3 0.02 - 0.50
Basophils 0.11 thou/mm3 0.01 - 0.10
Platelet Count 172.0 thou/mm3 150.00 - 450.00
(Electrical impedence)

*265315361*
Page 1 of 7
.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

*265315361*
Page 2 of 7
.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA @ 94.00 mg/dL 70.00 - 100.00
(Hexokinase)

CREATININE, SERUM @ 0.47 mg/dL 0.51 - 0.95

(Compensated Jaffe's reaction, IDMS traceable)

ALT (SGPT), SERUM @ 22 U/L <35

(IFCC without P5P)

ALKALINE PHOSPHATASE (ALP), SERUM @ 88 U/L 30 - 120

(IFCC)

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*265315361*
Page 3 of 7
.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

BILIRUBIN TOTAL, DIRECT AND INDIRECT, SERUM @

(DPD, Calculated)

Bilirubin Total 0.40 mg/dL 0.30 - 1.20

Bilirubin Direct 0.09 mg/dL <0.20

Bilirubin Indirect 0.31 mg/dL <1.10

HEPATITIS B SURFACE ANTIGEN (HBsAg), RAPID Non-Reactive

SCREENING TEST, SERUM @
(Lateral Flow Immunochromatography)
Interpretation
-------------------------------------------------------------------
| RESULT | REMARKS |
|--------------|----------------------------------------------------|
| Reactive | Indicates presence of Hepatitis B Surface Antigen. |
|--------------|----------------------------------------------------|
| Non-Reactive | Indicates absence of Hepatitis B Surface Antigen. |
-------------------------------------------------------------------

* All reactive results should be subjected for confirmatory test which can be requested as Test Code S116.

Note
1. This is a screening test and the result should be interpreted in conjunction with clinical findings and
other diagnostic tests.
2. This assay is used for qualitative detection of Hepatitis B Surface Antigen (HBsAg) in serum samples
and cannot differentiate between the stages of Hepatitis B viral infection. Detection of HBsAg may be
observed in Hepatitis B viral infection for transient period of time after HBV vaccination.
3. The Hepatitis B Surface Antigen Rapid Test cannot detect less than 1 ng/mL of HBsAg in specimens.
Sensitivity and Specificity of this HBsAg test by Immunochromatography is 99.8% and 99.2%
respectively.
4. False negative reaction may be due to processing of sample collected early in the course of disease
or presence of mutant forms of HBsAg.
5. For monitoring HBsAg levels, Quantitative HBsAg assay is recommended.
6. Test conducted on serum.

Comment
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*265315361*
Page 4 of 7
.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

Hepatitis B Virus (HBV) is a member of the Hepadna virus family causing infections of the liver with variable
clinical features. Hepatitis B is transmitted by blood and body fluids, sexually and from mother to fetus. In
most cases HBV hepatitis is self limiting, but 1-2% adolescents and adults develop Chronic Hepatitis.
Frequency of chronic HBV infection is 5-10% in immunocompromised patients and 80% in neonates.
HBsAg is the first serological marker after infection with HBV appearing 1-10 weeks after exposure and 2-8
weeks before the onset of clinical symptoms. HBsAg persists during the acute phase and disappears 12-20
weeks after onset of symptoms late in the convalescence period. Persistence of HBsAg for more than six
months indicates development of carrier state or Chronic liver disease.

Uses
· Routine screening of blood and blood products to prevent transmission of Hepatitis B virus (HBV) to
recipients
· To diagnose suspected HBV infection and monitor the status of infected individuals
· For Prenatal Screening of pregnant women

HEPATITIS C VIRUS (HCV), RAPID SCREENING Non-Reactive

TEST, SERUM @
(ICT)
Note
1. Reactive results suggest Asymptomatic / Infective state / Carrier state
2. Result may be Non reactive if an individual has not seroconverted at the time of testing

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*265315361*
Page 5 of 7
.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

THYROID PROFILE,TOTAL, SERUM @

(CLIA)
T3, Total 0.99 ng/mL 0.60 - 1.81

T4, Total 7.50 ug/dL 5.01 - 12.45

TSH 3.00 uIU/mL 0.35 - 5.50

Interpretation
-------------------------------------------------------------
|PREGNANCY |REFERENCE RANGE for TSH IN uIU/mL |
| |(As per American Thyroid |
| |Association) |
|--------------------------|----------------------------------|
|1st Trimester |0.10-2.50 |
|--------------------------|----------------------------------|
|2nd Trimester |0.20-3.00 |
|--------------------------|----------------------------------|
|3rd Trimester |0.30-3.00 |
-------------------------------------------------------------
Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50%, hence time of the day has
influence on the measured serum TSH concentrations.
2. Recommended test for T3 and T4 is unbound fraction or free levels as it is metabolically active.
3. Physiological rise in Total T3 / T4 levels is seen in pregnancy and in patients on steroid therapy.
Clinical Use
· Primary Hypothyroidism
· Hyperthyroidism
· Hypothalamic - Pituitary hypothyroidism
· Inappropriate TSH secretion
· Nonthyroidal illness
· Autoimmune thyroid disease
· Pregnancy associated thyroid disorders
· Thyroid dysfunction in infancy and early childhood

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*265315361*
Page 6 of 7
.

L89 - F PSC MEERUT 1

A-7, MEERUT MALL, DELHI ROAD,
MEERUT,U.P. 250002 PH- 0121 4011212
Meerut

Name : Mrs. MINNI Collected : 29/7/2019 8:50:00AM

Received : 29/7/2019 9:11:52AM
Lab No. : 265315361 Age: 30 Years Gender: Female Reported : 30/7/2019 11:45:46AM
A/c Status : P Ref By : Dr.ANIL KUMAR Report Status : Final

Test Name Results Units Bio. Ref. Interval

Dr Anand Chandrasekaran Annan Dr Himangshu Mazumdar Dr Nimmi Kansal Dr Anil Arora

MD (American Board of Pathology) MD, Biochemistry MD, Biochemistry MD, Pathology
PhD (Molecular & Cellular Pathology) Senior Consultant - Clinical Chemistry National Head - Clinical Chemistry & HOD Hematology &
HOD - Oncopathology & Biochemical Genetics Biochemical Genetics Immunohematology
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd

Dr Ritu Nayar Dr Shalabh Malik Dr Parul Chopra

MD, Microbiology MD, Microbiology MD, Laboratory Medicine
Deputy HOD - Microbiology & Serology National Head - Microbiology & Consultant
NRL - Dr Lal PathLabs Ltd Serology NRL - Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd
-------------------------------End of report --------------------------------

IMPORTANT INSTRUCTIONS

*Test results released pertain to the specimen submitted .*All test results are dependent on the quality of the sample received by the Laboratory .
*Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .*Sample
repeats are accepted on request of Referring Physician within 7 days post reporting.*Report delivery may be delayed due to unforeseen
circumstances. Inconvenience is regretted.*Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit
request within 72 hours post reporting.*Test results may show interlaboratory variations .*The Courts/Forum at Delhi shall have exclusive
jurisdiction in all disputes/claims concerning the test(s) & or results of test(s).*Test results are not valid for medico legal purposes. * Contact
customer care Tel No. +91-11-39885050 for all queries related to test results.
(#) Sample drawn from outside source.

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*265315361*
Page 7 of 7